Abstract
The efficacy of two routes of apomorphine, subcutaneous (SC) and sublingual (SL), successively administered in 7 Parkinsonian patients with motor fluctuations, was compared in reducing the daily duration of "off" phases. The mean duration of SC and SL treatment was 7.7 and 6.8 months respectively. The mean time spent in "off" phase was 55% after SC and 68% after SL treatment. The mean time before turning "on" after an "off" period was 14 minutes after SC and 28 minutes after SL treatment. Two patients developed stomatitis after SL route. SL apomorphine may be helpful in the treatment of motor fluctuations in PD.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Frankel J. P., Lees A. J., Kempster P. A., Stern G. M. Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1990 Feb;53(2):96–101. doi: 10.1136/jnnp.53.2.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hughes A. J., Webster R., Bovingdon M., Lees A. J., Stern G. M. Sublingual apomorphine in the treatment of Parkinson's disease complicated by motor fluctuations. Clin Neuropharmacol. 1991 Dec;14(6):556–561. doi: 10.1097/00002826-199112000-00008. [DOI] [PubMed] [Google Scholar]
- Kleedorfer B., Turjanski N., Ryan R., Lees A. J., Milroy C., Stern G. M. Intranasal apomorphine in Parkinson's disease. Neurology. 1991 May;41(5):761–762. doi: 10.1212/wnl.41.5.761-a. [DOI] [PubMed] [Google Scholar]
- Lees A. J., Montastruc J. L., Turjanski N., Rascol O., Kleedorfer B., Peyro Saint-Paul H., Stern G. M., Rascol A. Sublingual apomorphine and Parkinson's disease. J Neurol Neurosurg Psychiatry. 1989 Dec;52(12):1440–1440. doi: 10.1136/jnnp.52.12.1440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Montastruc J. L., Rascol O., Senard J. M., Gualano V., Bagheri H., Houin G., Lees A., Rascol A. Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study. Clin Neuropharmacol. 1991 Oct;14(5):432–437. doi: 10.1097/00002826-199110000-00007. [DOI] [PubMed] [Google Scholar]
- Poewe W., Kleedorfer B., Gerstenbrand F., Oertel W. Subcutaneous apomorphine in Parkinson's disease. Lancet. 1988 Apr 23;1(8591):943–943. doi: 10.1016/s0140-6736(88)91755-2. [DOI] [PubMed] [Google Scholar]
- Pollak P., Champay A. S., Gaio J. M., Hommel M., Benabid A. L., Perret J. Administration sous-cutanée d'apomorphine dans les fluctuations motrices de la maladie de Parkinson. Rev Neurol (Paris) 1990;146(2):116–122. [PubMed] [Google Scholar]
- Stibe C. M., Lees A. J., Kempster P. A., Stern G. M. Subcutaneous apomorphine in parkinsonian on-off oscillations. Lancet. 1988 Feb 20;1(8582):403–406. doi: 10.1016/s0140-6736(88)91193-2. [DOI] [PubMed] [Google Scholar]